SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-016569
Filing Date
2019-08-13
Accepted
2019-08-13 16:30:22
Documents
6
Period of Report
2019-08-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20190812_8k.htm 8-K 34982
2 EXHIBIT 4.1 ex_154773.htm EX-4.1 74104
3 EXHIBIT 4.2 ex_154865.htm EX-4.2 1122
4 EXHIBIT 5.1 ex_154772.htm EX-5.1 10185
5 card01.jpg GRAPHIC 547988
6 card02.jpg GRAPHIC 306611
  Complete submission text file 0001437749-19-016569.txt   1298990
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 191021062
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1